DESCRIPTION: See instructions. State the application's broad, long-term objectives and specific aims, making reference to the health relatedness of the project (i.e., relevance to the mission of the agency). Describe concisely the research design and methods for achieving these goals. Describe the rationale and techniques you will use to pursue these goals. In addition, in two or three sentences, describe in plain, lay language the relevance of this research to public health. If the application is funded, this description, as is, will become public information. Therefore, do not include proprietary/confidential information. DO NOT EXCEED THE SPACE PROVIDED. Autism Spectrum Disorder (ASD) is a common, often devastating neuropsychiatric condition with largely unknown pathophysiology. Although ASD has a multifactorial etiology, it encompasses a large genetic component. The investigators in this proposal aim to continue and enhance our collaborative effort that has produced significant advances in our understanding of ASD over the last four years and generated highly successful, open data and biomaterials resources for the research community, the NIMH Genetics Initiative and the Autism Genetic Resource Exchange (AGRE). Our Network has met or exceeded our original aims. We have built patient resources for research, identified rare and common ASD susceptibility alleles, defined models of ASD genetic susceptibility, provided evidence for convergent pathophysiology, and led development of animal and cell culture models. Here we propose to take a major new direction, filling a significant gap in ASD research, by recruiting underserved subjects of self-reported African ancestry (African-American;AA), an important population that has not previously been well-represented in ASD genetics research. Our Network involves six research sites and the AGRE DCC, collaborating in a systematic, comprehensive investigation of ASD genetics in order to identify rare mutations, chromosomal abnormalities, and common variation contributing to ASD susceptibility in the AA population. Specifically, we will enrich existing resources by recruiting at least 600 AA probands and additional family members. Our recruitment plan includes an embedded health disparities project that will evaluate access to care for AAs with ASD and clarify factors influencing participation of AA individuals in genetic research. We will employ novel methods to define the ancestral origin of specific chromosomal segments and ascertain the background on which susceptibility alleles occur. We will perform follow up GWA on ASD-related endophenotypes or co-variates, such as language delay, sex and head circumference. In parallel, we will conduct whole exome sequencing (WES) and analysis of copy number variation (CNV) using 2.5M SNP arrays yielding high resolution molecular karyotypes and providing a resource on genome-wide CNV and coding sequence variation (SNV) in ASD. Gene expression profiling and network analysis will be used to prioritize variants. Genetic risk factors identified in the mostly European samples will be tested for association in the AA sample to determine whether these cohorts share the same genetic risk factors, using a sample size providing power to replicate previous associations and to identify rare, recurrent CNV and SNV. The observation of new forms or different population frequencies of ASD-related variation in this sample as well as the sharing of most CNV and SNV with other cohorts are both outcomes that will have great significance for future studies and clinical care. As has been our practice, our Network will make all phenotypic and genotype data accessible via the internet on a rolling basis, further enhancing the value of this resource to the community.
This Network of Investigators proposes to fill a significant gap in autism research by recruiting underserved subjects of self-reported African ancestry (African-Americans), an important population that has not previously been well represented in ASD genetics. We will enrich current genetic repositories and use comprehensive methods to find genes, while at the same time evaluating disparities in diagnosis and access to care for this population.
|O'Connor, Shawn David; Cabrera, Omar Hoseá; Dougherty, Joseph D et al. (2017) Dexmedetomidine protects against glucocorticoid induced progenitor cell apoptosis in neonatal mouse cerebellum. J Matern Fetal Neonatal Med 30:2156-2162|
|Dougherty, Joseph D; Yang, Chengran; Lake, Allison M (2017) Systems biology in the central nervous system: a brief perspective on essential recent advancements. Curr Opin Syst Biol 3:67-76|
|Watanabe, Momoko; Buth, Jessie E; Vishlaghi, Neda et al. (2017) Self-Organized Cerebral Organoids with Human-Specific Features Predict Effective Drugs to Combat Zika Virus Infection. Cell Rep 21:517-532|
|Cantor, R M; Navarro, L; Won, H et al. (2017) ASD restricted and repetitive behaviors associated at 17q21.33: genes prioritized by expression in fetal brains. Mol Psychiatry :|
|Ellis, Shannon E; Gupta, Simone; Moes, Anna et al. (2017) Exaggerated CpH methylation in the autism-affected brain. Mol Autism 8:6|
|Parikshak, Neelroop N; Swarup, Vivek; Belgard, T Grant et al. (2016) Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature 540:423-427|
|Ellis, S E; Panitch, R; West, A B et al. (2016) Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia. Transl Psychiatry 6:e817|
|Won, Hyejung; de la Torre-Ubieta, Luis; Stein, Jason L et al. (2016) Chromosome conformation elucidates regulatory relationships in developing human brain. Nature 538:523-527|
|Ruzzo, Elizabeth K; Geschwind, Daniel H (2016) Schizophrenia genetics complements its mechanistic understanding. Nat Neurosci 19:523-5|
|Maloney, Susan E; Khangura, Eakta; Dougherty, Joseph D (2016) The RNA-binding protein Celf6 is highly expressed in diencephalic nuclei and neuromodulatory cell populations of the mouse brain. Brain Struct Funct 221:1809-31|
Showing the most recent 10 out of 44 publications